Article
Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Cellular oncology (Dordrecht, Netherlands) - 1 Oct 2014
Sie Daoud, Snijders Peter J F, Meijer Gerrit A, Doeleman Marije W, van Moorsel Marinda I H, van Essen Hendrik F, Eijk Paul P, Grünberg Katrien, van Grieken Nicole C T, Thunnissen Erik, Verheul Henk M, Smit Egbert F, Ylstra Bauke, Heideman Daniëlle A M
Abstract excerpt
PURPOSE: Next generation DNA sequencing (NGS) holds promise for diagnostic applications, yet implementation in routine molecular pathology practice requires performance evaluation on DNA derived from routine formalin-fixed paraffin-embedded (FFPE) tissue specimens. The current study presents a comprehensive analysis of TruSeq Amplicon Cancer Panel-based NGS using a MiSeq Personal sequencer (TSACP-MiSeq-NGS) for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
